Quick Answer
InflaRx N.V. reported Total Assets of $55.22 million for fiscal year 2025.
InflaRx N.V. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $55.22M -27.4% |
$76.02M -36.8% |
$120.21M +17.4% |
$102.40M -18.2% |
$125.14M +41.9% |
$88.22M -27.4% |
| R&D Expense | $25.72M -27.3% |
$35.36M -13.8% |
$41.02M +9.3% |
$37.53M +5.1% |
$35.70M +39.0% |
$25.68M -42.4% |
| Gross Profit | -$7.24M -129.7% |
-$3.15M -571.7% |
-$469.2K | — | — | — |
- InflaRx N.V. reported Total Assets of $55.22 million for fiscal year 2025.
- InflaRx N.V. showed a decrease of -27.4% in Total Assets compared to the prior fiscal year.
- InflaRx N.V. reported R&D Expense of $25.72 million for fiscal year 2025.
- InflaRx N.V. showed a decrease of -27.3% in R&D Expense compared to the prior fiscal year.
- InflaRx N.V. reported Gross Profit of -$7.24 million for fiscal year 2025.
- InflaRx N.V. showed a decrease of -129.7% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: